Dataset from Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008965
下载链接
链接失效反馈官方服务：
资源简介：
Evaluate the efficacy of treatment with high-titer Anti- SARS-CoV-2 plasma versus control
(SARS-CoV-2 non-immune plasma) in subjects exposed to Coronavirus disease (COVID-19) at day
28.
创建时间：
2025-08-12
